A Randomized Double-Blind, Placebo-controlled Study to Assess the Efficacy and Safety of Three Doses of Aplindore MR (1,3 and 6 mg Twice Daily) in Patients with Early Parkinson Disease (Aplindore-211)

Grants and Contracts Details

Description

No Abstract Available
StatusFinished
Effective start/end date10/1/08 → 4/30/10

Funding

  • University of Rochester: $6,993.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint